Gene Patents in Australia: Options for Reform

关于基因专利申请、获取药物、生物剽窃和遗传资源所有权的争议，导致许多人质疑专利法是否适用于生物技术。专利是否阻碍了药物、研究工具和新作物等有益技术的获取，同时阻碍了医疗保健和农业的政策选择？该项目解决了对生物技术专利的影响进行全面研究的迫切需要，批判性地审查海外发展，将生物技术置于知识产权法的更广泛政策背景下，并对模式进行实证分析，而不是依赖于在该领域占主导地位的轶事和零碎的研究。

Controversies over the upsurge in gene patenting, access to pharmaceuticals, biopiracy, and ownership of genetic resources, lead many to question whether patent law is appropriate for biotechnology. Do patents thwart access to beneficial technologies such as drugs, research tools and new crops, while hampering policy options for health care and agriculture? This project addresses the urgent need for a comprehensive study of the impact of biotech patenting, critically reviewing overseas developments, setting biotechnology in the broader policy context of intellectual property law, and empirically analysing patterns rather than relying on the anecdotal and piecemeal studies that dominate this area.